You have 9 free searches left this month | for more free features.

Zortress

Showing 1 - 25 of 74

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Uterine Sarcoma Trial (Everolimus)

Available
  • Uterine Sarcoma
  • (no location specified)
Aug 25, 2022

Renal Failure Trial in Columbus (Everolimus, Sirolimus)

Completed
  • Renal Failure
  • Columbus, Ohio
    The Ohio State University Wexner Medical Center
Nov 2, 2021

Idiopathic Subglottic Tracheal Stenosis Trial in Baltimore (Everolimus Oral Tablet)

Recruiting
  • Idiopathic Subglottic Tracheal Stenosis
  • Everolimus Oral Tablet
  • Baltimore, Maryland
    Johns Hopkins Outpatient Center
Jul 28, 2022

Liver Transplant Trial in Boston (biological, procedure, drug)

Recruiting
  • Liver Transplant
  • arTreg-CSB
  • +4 more
  • Boston, Massachusetts
    Massachusetts General Hospital: Transplantation
Jan 30, 2023

Cutaneous Squamous Cell Carcinoma, Advanced Cancer Trial in Boston (Cemiplimab, Everolimus, Sirolimus)

Recruiting
  • Cutaneous Squamous Cell Carcinoma
  • Advanced Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 19, 2023

Gastrointestinal Stromal Tumor Trial (Everolimus)

Temporarily not available
  • Gastrointestinal Stromal Tumor
  • (no location specified)
May 5, 2022

Renal Transplant Trial in Toledo (Arm 1 Everolimus/Reduced dose tacrolimus)

Completed
  • Renal Transplant
  • Arm 1 Everolimus/Reduced dose tacrolimus
  • Toledo, Ohio
    University of Toledo, Health Science Campus
May 2, 2022

Liver Transplant Trial in San Francisco (biological, procedure, drug)

Recruiting
  • Liver Transplant
  • arTreg
  • +4 more
  • San Francisco, California
    University of California, San Francisco
Sep 13, 2022

Advanced Malignant Tumor, Metastatic Malignant Tumor, Recurrent Malignant Tumor Trial in Houston (Everolimus, Laboratory

Recruiting
  • Advanced Malignant Neoplasm
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 9, 2022

Liver Transplantation Trial in Chicago (Tacrolimus Withdrawal and Everolimus Monotherapy)

Completed
  • Liver Transplantation
  • Tacrolimus Withdrawal and Everolimus Monotherapy
  • Chicago, Illinois
    Northwestern University Comprehensive Transplant Center
Apr 6, 2021

Advanced Carcinoid Tumor, Digestive System Neuroendocrine Tumor, Multiple Endocrine Neoplasia Type 1 Trial in Houston

Recruiting
  • Advanced Carcinoid Tumor
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Metastatic Midgut Neuroendocrine Tumor, Unresectable Midgut Neuroendocrine Tumor Trial (procedure, drug, other)

Not yet recruiting
  • Metastatic Midgut Neuroendocrine Tumor
  • Unresectable Midgut Neuroendocrine Tumor
  • Biospecimen Collection
  • +5 more
  • (no location specified)
Mar 16, 2023

Delayed Graft Function Trial in Columbus (Belatacept, Everolimus)

Terminated
  • Delayed Graft Function
  • Columbus, Ohio
    The Ohio State Universtiy Wexner Medical Center
Sep 17, 2021

Carcinoma, Hepatocellular Trial in United States (Everolimus, Tacrolimus, Myfortic)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • San Francisco, California
  • +8 more
Jul 19, 2022

Kidney Transplant Rejection, Gastrointestinal Disorder, Functional Trial in Saint Louis (Everolimus, Mycophenolic Acid)

Terminated
  • Kidney Transplant Rejection
  • Gastrointestinal Disorder, Functional
  • Saint Louis, Missouri
    Washington University
Aug 7, 2020

Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Trial

Recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 17, 2022

Endometrial Cancer Trial in Pensacola, Voorhees, Houston (Metformin, Letrozole, Everolimus)

Active, not recruiting
  • Endometrial Cancer
  • Pensacola, Florida
  • +5 more
Feb 9, 2022

Breast Cancer Trial in New York (Carboplatin, Everolimus)

Recruiting
  • Breast Cancer
  • New York, New York
  • +2 more
Oct 22, 2021

Kidney Transplant, Adult Living Donor Kidney Transplant Recipients, Renal Transplant Trial in United States (biological, drug,

Recruiting
  • Kidney Transplant
  • +3 more
  • Polyclonal Regulatory T Cells
  • +10 more
  • Birmingham, Alabama
  • +5 more
Feb 22, 2022

Advanced Lung Carcinoid Tumor, Functioning Lung Carcinoid Tumor, Locally Advanced Lung Neuroendocrine Tumor Trial in Boston,

Recruiting
  • Advanced Lung Carcinoid Tumor
  • +11 more
  • Boston, Massachusetts
  • +1 more
Jul 19, 2022

Recurrent Endometrial Carcinoma, Recurrent Endometrial Endometrioid Adenocarcinoma, Refractory Endometrial Carcinoma Trial in

Recruiting
  • Recurrent Endometrial Carcinoma
  • +12 more
  • Houston, Texas
  • +1 more
Sep 22, 2022

Adenocarcinoma, Pancreatic Tumors Trial in Saint Louis, Nashville (X-82, Everolimus)

Terminated
  • Adenocarcinoma
  • Pancreatic Neoplasms
  • Saint Louis, Missouri
  • +1 more
Jun 15, 2021

Advanced Malignant Solid Tumor, EGFR Gene Amplification, EGFR Gene Mutation Trial in Houston (Everolimus, Neratinib,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 25, 2022

Kidney Transplant Rejection Trial in Cincinnati (Belatacept, Everolimus, mycophenolate mofetil)

Recruiting
  • Kidney Transplant Rejection
  • Cincinnati, Ohio
  • +1 more
Apr 14, 2021

Recurrent World Health Organization (WHO) Grade II Glioma Trial in United States (Everolimus, Trametinib)

Recruiting
  • Recurrent World Health Organization (WHO) Grade II Glioma
  • Birmingham, Alabama
  • +11 more
May 6, 2022